Aptima HBV Quant Assay

FDA Premarket Approval P170025 S016

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Change the shipping container used to ship refrigerated product.

DeviceAptima HBV Quant Assay
Generic NameHepatitis Viral B Dna Detection
ApplicantHologic, Inc
Date Received2020-07-09
Decision Date2020-07-21
Product CodeMKT 
Advisory CommitteeMicrobiology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Hologic, Inc 10210 Genetic Center Drive san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P170025Original Filing
S016 2020-07-09 30-day Notice
S015 2020-02-12 30-day Notice
S014 2019-12-23 Real-time Process
S013 2019-06-21 Normal 180 Day Track
S012 2019-04-19 30-day Notice
S011 2019-03-27 30-day Notice
S010 2019-03-18 Real-time Process
S009 2019-02-21 30-day Notice
S008 2019-01-31 30-day Notice
S007 2018-12-31 Real-time Process
S006 2018-11-29 30-day Notice
S005 2018-10-03 30-day Notice
S004 2018-05-11 135 Review Track For 30-day Notice
S003 2018-04-20 30-day Notice
S002 2018-03-12 30-day Notice
S001 2018-02-21 Normal 180 Day Track

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.